Essential cookies keep the library working. With your permission, we'd also like to use analytics to see what's useful and improve the experience. Read our Privacy Policy or Cookie Policy.
Checking your access to this record.
The outbreak of 2019-novel coronavirus disease (COVID-19) that is caused by SARS-CoV-2 has spread rapidly in China, and has developed to be a Public Health Emergency of International Concern. However, no specific antiviral treatments or vaccines are available yet. This work aims to share strategies and candidate antigens to develop safe and effective vaccines against SARS-CoV-2.
Copy in another style
Shang, W., Yang, Y., Rao, Y., & Xiancai, R. (2020). The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines. npj Vaccines, 5(1), 18–18. https://doi.org/10.1038/s41541-020-0170-0
Metadata is harvested from open-access indexes and can be incomplete. Check a citation against the published version before relying on it — see our open access & attribution policy.
Alexandre Gallerand, Stoyan Ivanov
In Discovery Immunology
Lucía Toca Pérez, Miriam Alonso Fernández
In Clínica Contemporánea
Eduardo de Santibáñes, Claudio Bassi
In Annals of Surgery
John P. Stein, Stuart D. Boyd
In Journal of Clinical Oncology